List view / Grid view
4 September 2015 | By Victoria White
Researchers have identified a pathway that causes resistance to chemotherapy and radiation treatments and a new drug, KG5, that targets this pathway...
3 September 2015 | By Victoria White
The University of Brighton has announced it is sharing in a €5.9m EU grant to support the development of a new treatment for chronic liver disease...
3 September 2015 | By Victoria White
Horizon and Redx have announced a new research collaboration to progress Redx’s pan-RAF inhibitor programme, for out-licensing in oncology indications...
2 September 2015 | By Victoria White
Nearly all advanced oesophageal cancers harbour genetic mutations that can be targeted with emerging drug therapies, according to a new study...
2 September 2015 | By Victoria White
ESCMID advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms...
1 September 2015 | By Nick Jackson
Dr Koslowski brings over 15 years’ experience across biopharmaceutical research and development, specialising in drug target discovery and clinical validation...
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
24 August 2015 | By Victoria White
Motif Bio has announced the topline results of an independent report that show iclaprim is effective in vitro against a range of Gram-positive bacteria...
20 August 2015 | By Victoria White
Janus Biotherapeutics has entered into a collaboration with Roche for the development of a small molecule toll-like receptor (TLR) inhibitor...
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
10 August 2015 | By Charlotte Batchelor, Drug Target Review
Allergy Therapeutics has announced the publication of a key paper and featured article in the World Allergy Journal about proteomics in the field of allergy...
4 August 2015 | By Victoria White
MorphoSys and G7 Therapeutics have signed an agreement to collaborate on novel antibody therapeutics targeting G protein-coupled receptors (GPCRs)...
4 August 2015 | By Victoria White
The oncology drug pipeline is far larger than any other therapy area with 6,484 products in active development across all indications...
4 August 2015 | By Victoria White
Researchers have used nanoparticles to breach the human airway mucus barrier of lung tissue - a finding that could lead to effective drug delivery systems...
3 August 2015 | By Victoria White
AstraZeneca and Isis Pharmaceuticals are to collaborate to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases...
